Filing Details

Accession Number:
0001144204-15-010782
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-18 21:53:23
Reporting Period:
2014-01-29
Filing Date:
2015-02-18
Accepted Time:
2015-02-18 21:53:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Biosciences Inc SGMO Biological Products, (No Disgnostic Substances) (2836) 680359556
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315082 Ra Capital Healthcare Fund Lp C/O Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
No No No Yes
1346824 Ra Capital Management, Llc 20 Park Plaza, Suite 1200
Boston MA 02116
No No No Yes
1384859 Peter Kolchinsky C/O Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-07 35,736 $12.09 4,857,972 No 4 P Direct
Common Stock Disposition 2014-05-08 20,825 $12.39 4,837,147 No 4 S Direct
Common Stock Disposition 2014-05-08 62,475 $12.40 4,774,672 No 4 S Direct
Common Stock Disposition 2014-05-12 19,389 $13.01 4,755,283 No 4 S Direct
Common Stock Disposition 2014-05-12 10,270 $13.06 4,745,013 No 4 S Direct
Common Stock Disposition 2014-05-13 56,060 $13.12 4,688,953 No 4 S Direct
Common Stock Disposition 2014-05-22 15,578 $13.51 4,673,375 No 4 S Direct
Common Stock Disposition 2014-05-22 40,818 $13.58 4,632,557 No 4 S Direct
Common Stock Disposition 2014-05-23 51,597 $13.27 4,580,960 No 4 S Direct
Common Stock Disposition 2014-05-27 154,574 $13.55 4,426,386 No 4 S Direct
Common Stock Disposition 2014-05-27 108,863 $13.56 4,317,523 No 4 S Direct
Common Stock Disposition 2014-05-28 124,387 $13.42 4,193,136 No 4 S Direct
Common Stock Disposition 2014-05-28 24,302 $13.47 4,168,834 No 4 S Direct
Common Stock Disposition 2014-05-29 9,390 $13.51 4,159,444 No 4 S Direct
Common Stock Disposition 2014-05-29 146,285 $13.53 4,013,159 No 4 S Direct
Common Stock Disposition 2014-05-30 41,651 $13.38 3,971,508 No 4 S Direct
Common Stock Disposition 2014-05-30 24,233 $13.45 3,947,275 No 4 S Direct
Common Stock Disposition 2014-06-03 76,833 $12.86 3,870,442 No 4 S Direct
Common Stock Disposition 2014-06-04 20,659 $13.08 3,849,783 No 4 S Direct
Common Stock Disposition 2014-06-04 20,826 $13.11 3,828,957 No 4 S Direct
Common Stock Disposition 2014-06-04 29,155 $13.11 3,799,802 No 4 S Direct
Common Stock Disposition 2014-06-05 918,499 $13.00 2,881,303 No 4 S Direct
Common Stock Disposition 2014-06-05 586 $13.11 2,880,717 No 4 S Direct
Common Stock Disposition 2014-06-05 18,377 $13.98 2,862,340 No 4 S Direct
Common Stock Disposition 2014-06-05 32,899 $14.13 2,829,441 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund"). RA Capital Management, LLC (the "Adviser") is the general partner of the Fund, and Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and therefore disclaim any obligation to report ownership of the reported securities other than on behalf of the Fund. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any of the securities reported herein. The number of shares reported in Col 5 of Table I and the number of options reported in Col 9 of Table II reflect the number of shares or options, as applicable, beneficially owned by the Fund as of the time of the last transaction reported herein.